MSD's combination of PD-1 inhibitor Keytruda and experimental LAG-3 inhibitor favezelimab has failed a phase 3 trial in patients with previously treated PD-L1-positive microsatellite stable (MSS ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NPR coverage of national news, U.S. politics, elections, business, arts, culture, health and science, and technology. Subscribe to the NPR Nation RSS feed.

Reuters.com is your online source for the latest Americas news stories and current events, ensuring our readers up to date with any breaking news developments ...

Find the latest stock market news from every corner of the globe at Reuters.com, your online source for breaking international market and finance news ...